Pharmacological studies indicate that vasoactive intestinal peptide (VIP) may be necessary for normal embryonic development in the mouse. For example, VIP antagonist treatment before embryonic day 11 resulted in developmental delays, growth restriction, modified adult brain chemistry and reduced social behavior. Here, developmental milestones, growth, and social behaviors of neonates of VIP-deficient mothers (VIP +/À) mated to VIP +/À males were compared with the offspring of wild type mothers (VIP +/+) mated to VIP +/+ and +/À males, to assess the contributions of both maternal and offspring VIP genotype. Regardless of their own genotype, all offsprings of VIP-deficient mothers exhibited developmental delays. No delays were seen in the offspring of wild type mothers, regardless of their own genotype. Body weights were significantly reduced in offspring of VIP-deficient mothers, with VIP null (À/À) the most affected. Regardless of genotype, all offspring of VIPdeficient mothers expressed reduced maternal affiliation compared with wild type offspring of wild type mothers; +/À offspring of wild type mothers did not differ in maternal affiliation from their wild type littermates. Play behavior was significantly reduced in all offsprings of VIPdeficient mothers. Maternal behavior did not differ between wild type and VIP-deficient mothers, and cross-fostering of litters did not change offspring development, indicating that offspring deficits were induced prenatally. This study illustrated that the VIP status of a pregnant mouse had a greater influence on the growth, development and behavior of her offspring than the VIP genotype of the offspring themselves. Deficiencies were apparent in +/+, +/À and À/À offspring born to VIP-deficient mothers; no deficiencies were apparent in +/À offspring born to normal mothers. These results underscore the significant contribution of the uterine environment to normal development and indicate a potential usefulness of the VIP knockout mouse in furthering the understanding of neurodevelopmental disorders with social behavior deficits such as autism. Published by Elsevier Ltd on behalf of ISDN
Recent studies have revealed that vasoactive intestinal peptide (VIP) regulates growth and development during the early postimplantation period of mouse embryogenesis characterized by neural tube closure and the initiation of neuronogenesis. Treatment of embryonic day 9 (E9) whole cultured mouse embryos with a dose range of VIP showed a concentration dependent and dramatic increase in growth and development over a 4 h period (Gressens et al., 1993; Dibbern et al., 1997; Hill et al., 1999; Glazner et al., 1999; Servoss et al., 2001) . Treatment with the same concentration range of the related peptide, pituitary adenylate cyclase polypeptide (PACAP) had no effect at low concentrations and an inhibitory effect on growth at higher concentrations (Hill et al., 1999) , illustrating the different roles of these peptides during development. Dramatic growth of whole cultured mouse embryos was also seen with downstream effectors of VIP including activity dependent neurotrophic factor (ADNF) (Dibbern et al., 1997; Glazner et al., 1999) and insulin-like growth factor-1 (IGF-1) (Servoss et al., 2001) , which was shown to be a mediator of VIP and ADNF actions during embryogenesis. VIP stimulated the expression of IGF-1 in mouse embryos (Servoss et al., 2001) , suggesting that the VIP- 
